Markets › India › NSE › REMUS

Remus Pharmaceuticals Ltd

NSE:REMUSHealthcare

——At close · Market cap —

INR millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Depreciation & amortization	1.8	1.5	4.8	11.2	18.7	27.6	+47.6%
Change in working capital	17.0	16.2	(32.7)	(224.4)	(331.5)	(336.8)	−1.6%
Operating cash flow	28.7	51.9	54.3	31.3	83.8	194.7	+132.3%
Capital expenditure	(0.7)	(0.7)	(27.3)	(120.2)	(39.8)	(145.7)	−266.1%
Dividends paid	0.0	0.0	0.0	(5.9)	(11.8)	(11.8)	+0.0%
Free cash flow	28.1	51.2	27.6	(88.9)	44.0	49.0	+11.4%

INR millionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.